United States · Series A startup

Who invested in Captozyme

One round we have observed, with the 0 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 15 Nov 2026

$3.4Mraised across 1 round since 2017, from 1 source

Latest round
Series A, $3.4MMar 2017
Investors
0
See who backed them

The rounds

  1. Mar 2017
    Series A$3.4M

    No investor was named in the report.

    Reported by FinSMEs

Funding filed with regulators

Captozyme filed one raise, $3.4M in all. Filings say how much was sold and to how many investors; they never name the investors.

  1. Sept 2016$3.4M1 investorequity, options, securities on exerciseSEC Form D

Founders and team

From the SEC filings it signed: 3 on the team.

  • Aaron B. CowleyExecutive Officer, Directori
  • Helena B. CowleyExecutive Officer, Directori
  • Qing-Shan B. LiExecutive Officer, Directori

Quick answers about Captozyme

How much has Captozyme raised?

Captozyme has raised $3.4M across 1 round since 2017.

When did Captozyme last raise?

Captozyme's most recent round was a Series A of $3.4M in Mar 2017.

What was Captozyme's biggest round?

Its most recent round, $3.4M in Mar 2017, is also its largest on record.

What stage is Captozyme at?

Captozyme's latest named round is a Series A, in Mar 2017.

Where is Captozyme based?

Captozyme is based in the United States.

Companies like Captozyme

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.